{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:12:48Z","timestamp":1760141568132,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejso.2020.08.008","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T12:57:30Z","timestamp":1597409850000},"page":"e62-e70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"PB","title":["Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients"],"prefix":"10.1016","volume":"46","author":[{"given":"Jia","family":"Ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-rong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-bin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-feng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-5527","authenticated-orcid":false,"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.08.008_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2020.08.008_bib2","doi-asserted-by":"crossref","first-page":"iv263","DOI":"10.1093\/annonc\/mdy161","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Glynne-Jones","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2020.08.008_bib3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1200\/JCO.2014.60.0213","article-title":"Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients","volume":"33","author":"Dienstmann","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.08.008_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1634\/theoncologist.2014-0325","article-title":"Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors","volume":"20","author":"Kopetz","year":"2015","journal-title":"Oncol"},{"key":"10.1016\/j.ejso.2020.08.008_bib5","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.2147\/OTT.S114090","article-title":"hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy","volume":"9","author":"Muratori","year":"2016","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.ejso.2020.08.008_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/gastro\/goz006","article-title":"Challenges and solutions in patient treatment strategies for stage II colon cancer","volume":"7","author":"Fotheringham","year":"2019","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.ejso.2020.08.008_bib7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.molmed.2015.05.005","article-title":"Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system","volume":"21","author":"Pico de Coana","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejso.2020.08.008_bib8","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2020.08.008_bib9","first-page":"285","article-title":"The potential value of immunotherapy in colorectal cancers: review of the evidence for programmed death-1 inhibitor therapy","volume":"15","author":"Toh","year":"2016","journal-title":"Clin Colorectal Canc"},{"key":"10.1016\/j.ejso.2020.08.008_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41588-018-0286-6","article-title":"Discovery of common and rare genetic risk variants for colorectal cancer","volume":"51","author":"Huyghe","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejso.2020.08.008_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2018.10.030","article-title":"NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver","volume":"442","author":"Deng","year":"2019","journal-title":"Canc Lett"},{"key":"10.1016\/j.ejso.2020.08.008_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41416-018-0198-3","article-title":"Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer","volume":"120","author":"Schiffmann","year":"2019","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejso.2020.08.008_bib13","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3892\/or.2014.3421","article-title":"Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice","volume":"32","author":"He","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejso.2020.08.008_bib14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1245\/s10434-015-4889-1","article-title":"A\u00a0novel immune marker model predicts oncological outcomes of patients with colorectal cancer","volume":"23","author":"Chen","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.008_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/bioinformatics\/btr028","article-title":"HTSanalyzeR: an R\/Bioconductor package for integrated network analysis of high-throughput screens","volume":"27","author":"Wang","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejso.2020.08.008_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.ejso.2020.08.008_bib17","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejso.2020.08.008_bib18","first-page":"e569","article-title":"Stage-based variation in the effect of primary tumor side on all stages of colorectal cancer recurrence and survival","volume":"17","author":"Lee","year":"2018","journal-title":"Clin Colorectal Canc"},{"key":"10.1016\/j.ejso.2020.08.008_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/annonc\/mdx794","article-title":"Prognostic markers for colorectal cancer: estimating ploidy and stroma","volume":"29","author":"Danielsen","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2020.08.008_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050598","article-title":"Identification of 42 genes linked to stage II colorectal cancer metastatic relapse","volume":"17","author":"Al-Temaimi","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2020.08.008_bib21","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/cncr.31214","article-title":"The clinical implications of immunogenomics in colorectal cancer: a path for precision medicine","volume":"124","author":"Riley","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.08.008_bib22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2020.08.008_bib23","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-13-2830","article-title":"Prognostic and predictive values of the immunoscore in patients with rectal cancer","volume":"20","author":"Anitei","year":"2014","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.ejso.2020.08.008_bib24","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","article-title":"Cytokine patterns in patients with cancer: a systematic review","volume":"14","author":"Lippitz","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2020.08.008_bib25","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI31537","article-title":"A\u00a0cytokine-mediated link between innate immunity, inflammation, and cancer","volume":"117","author":"Lin","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ejso.2020.08.008_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.ejso.2020.08.008_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10555-007-9100-0","article-title":"Immune cells as mediators of solid tumor metastasis","volume":"27","author":"DeNardo","year":"2008","journal-title":"Canc Metastasis Rev"},{"key":"10.1016\/j.ejso.2020.08.008_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00005-017-0463-9","article-title":"Tumor-associated macrophages and regulatory T cells infiltration and the clinical outcome in colorectal cancer","volume":"65","author":"Waniczek","year":"2017","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1016\/j.ejso.2020.08.008_bib29","first-page":"3491","article-title":"CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer","volume":"58","author":"Naito","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2020.08.008_bib30","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.bjc.6602201","article-title":"Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis","volume":"91","author":"Chiba","year":"2004","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejso.2020.08.008_bib31","first-page":"4","article-title":"Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer","volume":"7","author":"Ohtani","year":"2007","journal-title":"Canc Immun"},{"key":"10.1016\/j.ejso.2020.08.008_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1177690","article-title":"CD169 identifies an activated CD8(+) T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients","volume":"5","author":"Zhang","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejso.2020.08.008_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/0008-5472.CAN-12-2325","article-title":"VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer","volume":"73","author":"Terme","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2020.08.008_bib34","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1158\/0008-5472.CAN-17-2538","article-title":"MPO promoter polymorphism rs2333227 enhances malignant phenotypes of colorectal cancer by altering the binding affinity of AP-2alpha","volume":"78","author":"Meng","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2020.08.008_bib35","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1038\/onc.2011.26","article-title":"Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer","volume":"30","author":"Albasri","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ejso.2020.08.008_bib36","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1038\/s41598-017-07491-3","article-title":"A\u00a0polymorphism in ABCC4 is related to efficacy of 5-FU\/capecitabine-based chemotherapy in colorectal cancer patients","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2020.08.008_bib37","doi-asserted-by":"crossref","first-page":"G401","DOI":"10.1152\/ajpgi.00110.2011","article-title":"The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?","volume":"301","author":"Azcarate-Peril","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ejso.2020.08.008_bib38","first-page":"1","article-title":"Role of gut microbiota in the development and treatment of colorectal cancer","author":"Lin","year":"2018","journal-title":"Digestion"},{"key":"10.1016\/j.ejso.2020.08.008_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/diseases6040109","article-title":"Gut microbiota, fusobacteria, and colorectal cancer","volume":"6","author":"Kelly","year":"2018","journal-title":"Diseases"},{"key":"10.1016\/j.ejso.2020.08.008_bib40","first-page":"2363","article-title":"Immunostimulation by propionibacteria--effects on immune status and antineoplastic treatment","volume":"15","author":"Isenberg","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2020.08.008_bib41","first-page":"1399","article-title":"Preoperative immunostimulation by Propionibacterium granulosum KP-45 in colorectal cancer","volume":"14","author":"Isenberg","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2020.08.008_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.micpath.2018.07.006","article-title":"Nisin, a potent bacteriocin and anti-bacterial peptide, attenuates expression of metastatic genes in colorectal cancer cell lines","volume":"123","author":"Norouzi","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ejso.2020.08.008_bib43","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMc1204069","article-title":"Intratumor heterogeneity and branched evolution","volume":"366","author":"Nash","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2020.08.008_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ags3.12182","article-title":"Cancer evolution and heterogeneity","volume":"2","author":"Mimori","year":"2018","journal-title":"Ann Gastroenterol Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320307009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320307009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:33:57Z","timestamp":1760060037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320307009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0748798320307009"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.08.008","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}